Current Infectious Disease Reports

, Volume 7, Issue 2, pp 154–158 | Cite as

The evolving role of HIV counseling and testing in resource-limited settings: HIV prevention and linkage to expanding HIV care access

  • Cheryl A. Liechty
Article

Abstract

The role of voluntary counseling and testing (VCT) of HIV in resource-limited settings has recently broadened from primarily that of a prevention intervention to its identification as the key entry point into expanding access to life-saving antiretroviral therapy, additional HIV-specific medical care, and other support services. To fulfill this expanded mandate, calls for routine counseling and testing in diverse health care settings, in addition to other innovative approaches to traditional VCT, are emerging. The efficacy and cost effectiveness of traditional facility-based VCT with respect to risk-behavior reduction of HIV have been demonstrated rigorously in resource-limited settings. Additional research is needed urgently to evaluate the feasibility, acceptability, and effectiveness of streamlined counseling and testing interventions that seek to reach as many individuals as possible to meet dual prevention and treatment goals.

Keywords

Voluntary Counseling Routine Counseling Ongoing Counseling Nonprimary Partner Seropositive Client 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Merson MH, Dayton JM, O’Reilly K: Effectiveness of HIV prevention interventions in developing countries.AIDS 2000, 14(Suppl 2):68–84.Google Scholar
  2. 2.
    Mellins CA, Ehrhardt AA: Families affected by pediatric acquired immunodeficiency syndrome: sources of stress and coping. J Dev Behav Pediatr 1994, 15:S54-S60.PubMedCrossRefGoogle Scholar
  3. 3.
    Chesney MA, Folkman S: Psychological impact of HIV disease and implications for intervention. Psychiatr Clin North Am 1994, 17:163–182.PubMedGoogle Scholar
  4. 4.
    Kelly JA, Murphy DA, Bahr GR, et al.: Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. Am J Psychiatry 1993, 150:1679–1686.PubMedGoogle Scholar
  5. 5.
    Grinstead OA, van der Straten A: Counselors’ perspectives on the experience of providing HIV counseling in Kenya and Tanzania: the Voluntary HIV1 Counseling and Testing Efficacy Study. AIDS Care 2000, 12:625–642.PubMedCrossRefGoogle Scholar
  6. 6.
    Sweat M, Gregorich S, Sangiwa G, et al.: Cost-effectiveness of voluntary HIV1 counseling and testing in reducing sexual transmission of HIV1 in Kenya and Tanzania. Lancet 2000, 8:113–121.CrossRefGoogle Scholar
  7. 7.
    Balmer D, Kihuho F: Characteristics of individuals and couples seeking HIV1 prevention services in Nairobi, Kenya: the voluntary HIV1 counseling and testing efficacy study. AIDS Behav 2000, 4:15–23.CrossRefGoogle Scholar
  8. 8.
    The impact of voluntary counseling and testing—a global review of the benefits and challenges. UNAIDS Best Practice Collection. Geneva, Switzerland: UNAIDS, 2001.Google Scholar
  9. 9.
    Alwano-Edyegu MG, Roels TH, Mokomane M, et al.: The effect of introducing antiretroviral therapy in the public setting on utilization of voluntary counseling and testing (VCT) services in Botswana, 2001–2003. Paper presented at the XV International AIDS Conference. Bangkok, Thailand, July 12, 2004.Google Scholar
  10. 10.
    Treating 3 million by 2005: Making it Happen, the World Health Organization (WHO) Strategy. Geneva, Switzerland: World Health Organization; 2003. Articulates WHO 3×5 goals, including an emphasis on expansion of HIV counseling and testing infrastructure.Google Scholar
  11. 11.
    Were W, Mermin J, Bunnell R, et al.: Home-based model for HIV voluntary counselling and testing. Lancet 2003, 361:1569.PubMedCrossRefGoogle Scholar
  12. 12.
    Molosiwa R, Mokomane M, Alwano-Edyegu MG, et al.: VCT on wheels: increasing access to voluntary HIV counseling and testing (VCT) services through use of mobile caravans —Botswana. Paper presented at the XV International AIDS Conference. Bangkok, Thailand; July 14, 2004.Google Scholar
  13. 13.
    Centers for Disease Control and Prevention: Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001, 9:1–57.Google Scholar
  14. 14.
    Downing RG, Otten RA, Marum E, et al.: Optimizing the delivery of HIV counseling and testing services: the Uganda experience using rapid HIV antibody test algorithms. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:384–388.PubMedGoogle Scholar
  15. 15.
    The Voluntary HIV1 Counseling and Testing Efficacy Study Group: Efficacy of voluntary HIV1 counseling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet 2000, 356:103–112. The first randomized trial testing efficacy of traditional HIV VCT.CrossRefGoogle Scholar
  16. 16.
    Sweat MD, Denison JA: Reducing HIV incidence in developing countries with structural and environmental interventions.AIDS 1995, 9(Suppl A):251–257.Google Scholar
  17. 17.
    Zachariah R, Spielmann MP, Harries AD, et al.: Voluntary counseling, HIV testing, and sexual behaviour among patients with tuberculosis in a rural district of Malawi. Int J Tuberc Lung Dis 2003, 7:65–71.PubMedGoogle Scholar
  18. 18.
    Grinstead OA, Gregorich SE, Choi KH, et al.: Positive and negative life events after counselling and testing: the voluntary HIV1 counseling and testing efficacy study. AIDS 2001, 15:1045–1052.PubMedCrossRefGoogle Scholar
  19. 19.
    Sweat M, Gregorich S, Sangiwa G, et al.: Cost-effectiveness of voluntary HIV1 counselling and testing in reducing sexual transmission of HIV1 in Kenya and Tanzania. Lancet 2000, 356:113–121.PubMedCrossRefGoogle Scholar
  20. 20.
    Marseille E, Hofmann PB, Kahn JG: HIV prevention before HAART in subSaharan Africa. Lancet 2002, 359:1851–1856.PubMedCrossRefGoogle Scholar
  21. 21.
    Muller O, Barugahare L, Schwartlander B, et al.: HIV prevalence, attitudes, and behaviour in clients of a confidential HIV testing and counseling centre in Uganda. AIDS 1992, 6:869–874.PubMedCrossRefGoogle Scholar
  22. 22.
    Mugerwa RD, Marum LH, Serwadda D: Human immunodeficiency virus and AIDS in Uganda. East Afr Med J 1996, 73:20–26.PubMedGoogle Scholar
  23. 23.
    Kassler WJ, Alwano-Edyegu MG, Marum E, et al. Rapid HIV testing with same-day results: a field trial in Uganda. Int J STD AIDS 1998, 9:134–138.PubMedCrossRefGoogle Scholar
  24. 24.
    Kipp W, Kabagambe G, Konde-Lule J: Low impact of a community-wide HIV testing and counseling program on sexual behavior in rural Uganda. AIDS Educ Prev 2001, 13:279–289.PubMedCrossRefGoogle Scholar
  25. 25.
    Pool R, Nyanzi S, Whitworth JA: Attitudes to voluntary counseling and testing for HIV among pregnant women in rural south-west Uganda. AIDS Care 2001, 13:605–615.PubMedCrossRefGoogle Scholar
  26. 26.
    Nyblade LC, Menken J, Wawer MJ, et al.: Population-based HIV testing and counseling in rural Uganda: participation and risk characteristics. J Acquir Immune Defic Syndr 2001, 28:463–470.PubMedGoogle Scholar
  27. 27.
    Worthington H: Where voluntary testing has produced results. AIDS Anal Afr 1997, 7:3.PubMedGoogle Scholar
  28. 28.
    Kamali A, Carpenter LM, Whitworth JA, et al.: Seven-year trends in HIV1 infection rates, and changes in sexual behaviour, among adults in rural Uganda. AIDS 2000, 14:427–434.PubMedCrossRefGoogle Scholar
  29. 29.
    Alwano-Edyegu MG: Knowledge is power: voluntary counseling and testing in Uganda. UNAIDS; June 1999.Google Scholar
  30. 30.
    DeCock KM, Marum E, Mbori-Ngacha D: A serostatus-based approach to HIV/AIDS prevention and care in Africa. Lancet 2003, 362:1847–1849. The authors advocate for expansion of routine HIV counseling and testing in an opt-out fashion.PubMedCrossRefGoogle Scholar
  31. 31.
    De Cock KM: Screening for tuberculosis and HIV in resource-poor countries. Lancet 1995, 345:873–874.PubMedCrossRefGoogle Scholar
  32. 32.
    Palmer DL, Mason PR, Pasi C, et al.: Value of mandatory testing for human immunodeficiency virus in a subSaharan hospital population. Clin Infect Dis 2000, 31:1258–1265.PubMedCrossRefGoogle Scholar
  33. 33.
    Kwesigabo G, Killewo JZ, Sandstrom A, et al.: Prevalence of HIV infection among hospital patients in north west Tanzania. AIDS Care 1999, 11:87–93.PubMedCrossRefGoogle Scholar
  34. 34.
    Anglaret X, Chene G, Attia A, et al.: Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV1-infected adults in Abidjan, Cote d’Ivoire: a randomised trial. Lancet 1999, 353:1463–1468.PubMedCrossRefGoogle Scholar
  35. 35.
    Wiktor SZ, Sassan-Morokro M, Grant AD, et al.: Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV1-infected patients with tuberculosis in Abidjan, Cote d’Ivoire: a randomised controlled trial. Lancet 1999, 353:1469–1475.PubMedCrossRefGoogle Scholar
  36. 36.
    Whalen CC, Johnson JL, Okwera A, et al.: A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus, Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997, 337:801–808.PubMedCrossRefGoogle Scholar
  37. 37.
    Provisional World Health Organization/UNAIDS Secretariat Recommendations on the Use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV/AIDS in Africa. Geneva, Switzerland: World Health Organization; 2000.Google Scholar
  38. 38.
    Policy Statement on Preventive Therapy Against Tuberculosis in People Living with HIV. Geneva, Switzerland: World Health Organization; 2001.Google Scholar
  39. 39.
    Pfizer to offer Diflucan free to patients with AIDS in least-developed countries. http://www.aegis.com/news/wsj/2001/WJ010617.html. Accessed June 6, 2001.Google Scholar
  40. 40.
    Bureau for Global Health, United States Agency for International Development: HIV/AIDS Country Profile: Uganda. 2003.Google Scholar
  41. 41.
    Ramsay S: Leading the way in African home-based palliative care. Lancet 2003, 362:1812–1813.PubMedCrossRefGoogle Scholar
  42. 42.
    Kaleeba N, Kalibala S, Kaseje M, et al.: Participatory evaluation of counseling, medical and social services of The AIDS Support Organization (TASO) in Uganda. AIDS Care 1997, 9:13–26.PubMedCrossRefGoogle Scholar
  43. 43.
    Kalibala S, Kaleeba N: AIDS and community-based care in Uganda: the AIDS support organization, TASO. AIDS Care 1989, 1:173–175.PubMedGoogle Scholar
  44. 44.
    Scaling up Antiretroviral Therapy in Resource-limited Settings: Treatment Guidelines for a Public Health Approach. Geneva, Switzerland: World Health Organization; 2003.Google Scholar
  45. 45.
    Quinn TC, Wawer MJ, Sewankambo N, et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000, 342:921–929.PubMedCrossRefGoogle Scholar
  46. 46.
    Cohen MS, Hosseinipour M, Kashuba A, et al.: Use of antiretroviral drugs to prevent sexual transmission of HIV. Curr Clin Top Infect Dis 2002, 22:214–251.PubMedGoogle Scholar
  47. 47.
    Hosseinipour M, Cohen MS, Vernazza PL, et al.: Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis 2002, 34:1391–1395.PubMedCrossRefGoogle Scholar
  48. 48.
    Kashuba AD, Dyer JR, Kramer LM, et al.: Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob Agents Chemother 1999, 43:1817–1826.PubMedGoogle Scholar
  49. 49.
    Chakraborty H, Sen PK, Helms RW, et al.: Viral burden in genital secretions determines male-to-female sexual transmission of HIV1: a probabilistic empiric model. AIDS 2001, 15:621–627.PubMedCrossRefGoogle Scholar
  50. 50.
    Wanyenze R, Liechty CA, Bangsberg DR, et al.: HIV risk behavior and acceptability of HIV counseling and testing in an urban teaching and national referral hospital in Kampala, Uganda. Paper presented at the XV International AIDS Conference. Bangkok, Thailand, July 14, 2004.Google Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Cheryl A. Liechty
    • 1
  1. 1.Positive Health Program, Department of Medicine-SFGHUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations